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Summary. A method for the in vitro generation of 
granulomas and its use in the analysis of the human 
granulomatous response is summarized. As a target for 
the cellular response L3 larvae of Nippostrongylus 
brasiliensis are coincubated with human mononuclear 
blood cells, and within seven to fourteen days the 
development of blood monocytes to mature macrophages 
and to epithelioid cells and multinucleated giant cells 
(MGC) as typical constituents of granulomas clustered 
around the nematode is observed. The following review 
describes the uses and applications of this model for 
phenotyping, functional, formation and modulating 
studies of granulomas and MGCs, taking into account its 
unique features compared to other in vitro models. 
With respect to MGC formation, procedures are 
described and examples are given which allow the 
phenotyping of these cells using immunofluorescence 
and immunohistological techniques. In addition, the 
potential of this model for illuminating functional 
aspects of MGC is described applying an isolation 
protocol for MGC and a subsequent reverse-transcriptase 
polymerase chain reaction method for the analysis of 
single cells. Moreover, the significance and relevance of 
using this granuloma model is discussed in the follow up 
analysis of in vivo findings of interleukin-6 expression in 
MGC of granulomas of patients with sarcoidosis. These 
in vivo results implicated a role for interleukin-6 in 
granuloma and MGC development. The  in vitro 
granuloma model was used to investigate potential 
modulatory effects of this cytokine by analysing the cell 
numbers and the number of MGC per in vitro 
granuloma, the size of the MGC formed, the fusion 
index and the morphology of the in vitro granuloma. The 
results demonstrated significant modulatory effects of 
interleukin-6 on the cell number per in vitro granuloma 
and on the morphology of the cells involved. 
Conceivably, elevated interleukin-6 levels may modulate 
granuloma formation with respect to the number of cells 
involved and in influencing distinct cell populations 
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involved in granuloma formation. 
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lntroduction 
The term granuloma is applied to any small nodular 
delimited aggregation of mononutlear ,inflammatory 
cells or a collection of modified macrophages, usually 
surrounded by a rim of lymphocytes and often 
containing multinucleated cells. Some granulomas 
contain eosinophils and plasma cells, and fibrosis is 
commonly seen around the lesion. Granuloma formation 
represents a chronic inflammatory response initiated by 
various infectious and noninfectious agents. The rather 
imprecise terminology reflects the complexity of the 
granulomatous responses found with respect to different 
granulomatous diseases, the cellular constituents 
involved,  and with respect  to the factors  and 
mechanisms leading to granuloma formation and 
resolution. Since the precise mechanism involved in 
the recruitment,  act ivat ion,  and maintenance of 
immune cells at granulomatous foci is not clearly 
understood, animal in vivo and human in vitro models 
mimicking granuloma formation are useful tools for 
the investigation of the mechanisms underlying 
granuloma formation. A large variety of in vivo 
granuloma models have been developed in the murine 
system (Warren, 1982; Kunkel et al., 1998) and with 
the advent of gene knock-out technology these models 
have become understandably attractive and effective 
for dissecting the mechanisms of granuloma formation 
and for elucidating the individual role of the mediators 
involved. They have thus contributed greatly to the 
understanding of the evolution of the granulomatous 
response from initiation to resolution or progression of 
disease. Nonetheless, even though these animal models 
involve mediator systems that are similar in both the 
human and the experimental model system, unique 
differences do exist that preclude them from exactly 
duplicating the human corollary disease (Kunkel et al., 








